Stocks · Healthcare · Drug Manufacturers - General
AbbVie Inc. ABBV
$262.82 +1.11% Close, Oct 2, 2026 · NYSE · Market cap $464.35B
High qualityLow risk
Next earnings report: Oct 30, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $3.55, up 68.1% year over year.
- Operating margin widened to 29.3% from 18.8% a year earlier.
- Earnings beat analyst estimates in each of the last 6 quarters (average surprise over the last four: +2.7%).
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
Growth59Neutral
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 46%
- EPS growth (TTM, YoY)Top 19%
- FCF growth (TTM, YoY)Bottom 49%
- Revenue growth, 3-year CAGRBottom 28%
- Revenue growth accelerationTop 37%
Quality96Exceptional
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 10%
- Gross marginTop 40%
- Operating marginTop 7%
- Cash conversion (OCF / net income)Top 10%
- Accruals (lower is better)Top 36%
- Net debt / EBITDA (lower is better)Bottom 30%
- Interest coverTop 21%
Value62Neutral
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 26%
- Free-cash-flow yieldTop 21%
- EBITDA / enterprise valueTop 27%
- Sales / enterprise valueBottom 36%
- P/E vs own 5-year history (lower is better)Bottom 25%
Momentum73Positive
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 39%
- 6-month returnTop 35%
- 1-year return vs S&P 500Bottom 47%
- Distance from 52-week highTop 2%
- Trend checklist (0–4)Top 7%
Revisions47Neutral
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 48%
- Consecutive EPS beatsTop 12%
- Share of analysts rating BuyBottom 42%
- Upside to consensus price targetBottom 17%
Stability95Exceptional
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 2%
- Maximum drawdown, 3 yearsTop 1%
- Beta vs S&P 500 (lower is better)Top 4%
- Net debt / EBITDA (lower is better)Bottom 30%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 9.5% | 10.4% | ↑ |
| EPS growth (YoY) | -13.3% | 68.1% | ↑ |
| Gross margin | 70.9% | 71.5% | ↑ |
| Operating margin | 18.8% | 29.3% | ↑ |
| FCF margin | 31.3% | 30.6% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 10.4% | 9.5% | ↑ | Top 46% |
| EPS growth (TTM, YoY) | 68.1% | -13.3% | ↑ | Top 19% |
| Gross margin | 71.5% | 70.9% | ↑ | Top 40% |
| Operating margin | 29.3% | 18.8% | ↑ | Top 7% |
| Net margin | 9.8% | 6.5% | ↑ | — |
| Free-cash-flow margin | 30.6% | 31.3% | ↓ | — |
| Return on invested capital | 13.5% | — | Top 10% | |
| Revenue growth, 3-year CAGR | 1.8% | — | Bottom 28% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 3.00×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -9.8%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.5%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -1.0 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 3.03×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 6.5×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 2.58%
- Net buyback yield (TTM)
- 0.52%
- Shareholder yield
- 3.10%
- Share count change, 1 year
- -0.1%
- Share count change, 3-year CAGR
- +0.0%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 3, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 6
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +2.7%
- Average 2-day reaction, last 8
- +0.8%
- Positive 20 days after report
- 6 of 8
Analysts
- Consensus price target
- $287.08
- Target vs current price
- +9.2%
- Analysts with a rating
- 43
- Share rating Buy or Strong Buy
- 72%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 31, 2026 | +1.1% | -2.5% | -5.3% | +0.3% | — |
| Apr 29, 2026 | +2.3% | +3.1% | +4.3% | +9.0% | +31.2% |
| Feb 4, 2026 | +2.3% | -3.8% | -1.4% | +4.7% | -6.4% |
| Oct 31, 2025 | +5.1% | -4.5% | -4.0% | -0.2% | -4.2% |
| Jul 31, 2025 | +3.1% | -0.2% | +3.7% | +9.9% | +20.6% |
| Apr 25, 2025 | +3.4% | +3.2% | +7.2% | +1.2% | +3.7% |
| Jan 31, 2025 | -27.5% | +4.7% | +9.9% | +19.0% | +9.5% |
| Oct 30, 2024 | +2.7% | +6.4% | +6.5% | -4.4% | -7.7% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 31, 2026 | $3.65 | $3.61 | +1.1% | $16.99B |
| Apr 29, 2026 | $2.65 | $2.59 | +2.3% | $15.00B |
| Feb 4, 2026 | $2.71 | $2.65 | +2.3% | $16.62B |
| Oct 31, 2025 | $1.86 | $1.77 | +5.1% | $15.78B |
| Jul 31, 2025 | $2.97 | $2.88 | +3.1% | $15.42B |
| Apr 25, 2025 | $2.46 | $2.38 | +3.4% | $13.34B |
| Jan 31, 2025 | $2.16 | $2.98 | -27.5% | $15.10B |
| Oct 30, 2024 | $3.00 | $2.92 | +2.7% | $14.46B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 74.0× | 48.6× | 71th | Top 26% |
| P/E (forward) | 18.7× | — | — | — |
| EV / EBITDA | 24.9× | — | — | Top 27% |
| EV / Sales | 8.21× | — | — | Bottom 36% |
| Free-cash-flow yield | 4.24% | — | — | Top 21% |
| Earnings yield | 1.35% | — | — | Top 26% |
P/E over the past five years
Range 19.3× – 162.2× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +7.5%
- Earnings per share growth (TTM)
- +68.1%
- Change in P/E multiple
- -26.0%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 17
- Days above the 200-day average
- 73
- 50-day average slope (20 days)
- +1.4%
- 200-day average slope (20 days)
- +1.4%
- Distance from 50-day average
- +1.9%
- Distance from 200-day average
- +13.5%
- RSI (14)
- 53.7
- Relative volume
- 1.42×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 21.5%
- Volatility vs own 5-year history
- 42th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.06
- Correlation with S&P 500
- 0.03
- Current drawdown from 1-year high
- -1.3%
- Maximum drawdown, 3 years
- -21.5%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Apr 8, 2022 | Jun 28, 2023 | -24.3% | 305 days | 154 days (Feb 7, 2024) |
| Mar 10, 2025 | Apr 21, 2025 | -21.5% | 29 days | 99 days (Sep 11, 2025) |
| Oct 1, 2025 | Apr 27, 2026 | -19.2% | 142 days | 42 days (Jun 26, 2026) |
| Oct 31, 2024 | Nov 15, 2024 | -19.1% | 11 days | 65 days (Feb 24, 2025) |
| Mar 28, 2024 | May 29, 2024 | -15.0% | 42 days | 39 days (Jul 25, 2024) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $464.35B
- P/E (TTM)
- 74.0
- EPS, diluted (TTM)
- $3.55
- Revenue (TTM)
- $64.39B
- Dividend yield
- 3.26%
- 52-week range
- $190.75 – $269.39
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $56.20B | $58.05B | $54.32B | $56.33B | $61.16B |
| Gross profit | $38.75B | $40.64B | $33.90B | $39.43B | $42.96B |
| Operating income | $17.92B | $18.12B | $12.76B | $9.14B | $20.09B |
| Net income | $11.54B | $11.84B | $4.86B | $4.28B | $4.23B |
| EPS (diluted) | $6.45 | $6.63 | $2.72 | $2.39 | $2.37 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.46B | $15.10B | $13.34B | $15.42B | $15.78B | $16.62B | $15.00B | $16.99B |
| Net income | $1.56B | -$22.0M | $1.29B | $938.0M | $186.0M | $1.82B | $699.0M | $3.61B |
| EPS (diluted) | $0.88 | -$0.02 | $0.72 | $0.53 | $0.10 | $1.02 | $0.39 | $2.04 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $22.78B | $24.94B | $22.84B | $18.81B | $19.03B |
| Capital expenditure | -$787.0M | -$695.0M | -$777.0M | -$974.0M | -$1.21B |
| Free cash flow | $21.99B | $24.25B | $22.06B | $17.83B | $17.82B |
| Dividends paid | -$9.26B | -$10.04B | -$10.54B | -$11.03B | -$11.66B |
| Net share buybacks | -$934.0M | -$1.49B | -$1.97B | -$1.71B | -$808.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $6.57B
- Total assets
- $135.13B
- Total liabilities
- $141.00B
- Total debt
- $70.82B
- Net debt
- $64.25B
- Shareholders’ equity
- -$5.93B
As of Jun 30, 2026 (filed Aug 3, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Oct 15, 2026 | $1.73 | Nov 16, 2026 |
| Jul 15, 2026 | $1.73 | Aug 14, 2026 |
| Apr 15, 2026 | $1.73 | May 15, 2026 |
| Jan 16, 2026 | $1.73 | Feb 17, 2026 |
| Oct 15, 2025 | $1.64 | Nov 14, 2025 |
| Jul 15, 2025 | $1.64 | Aug 15, 2025 |
| Apr 15, 2025 | $1.64 | May 15, 2025 |
| Jan 15, 2025 | $1.64 | Feb 14, 2025 |
Short interest
- Shares sold short
- 19,494,556
- Days to cover
- 4.48
- Change vs previous report
- -0.1%
FINRA short interest, settlement date Sep 15, 2026.